{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T17:25:51Z","timestamp":1648833951443},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1007\/bf03344069","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T17:00:17Z","timestamp":1397322017000},"page":"967-970","source":"Crossref","is-referenced-by-count":1,"title":["Reversible increase of serum activin A levels in women with Graves\u2019 disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Marco","family":"Centanni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Viceconti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Luisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. M.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Maiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Canettieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Petraglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BF03344069_CR1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1101\/gad.8.2.133","volume":"8","author":"DM Kingsley","year":"1994","unstructured":"Kingsley D.M. The TGF-\u03b2 superfamily: new members, new receptors and new genetic test of function in different organisms. Genes Dev. 1994, 8: 133\u2013146.","journal-title":"Genes Dev."},{"key":"BF03344069_CR2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","volume":"67","author":"J Massagu\u00e9","year":"1998","unstructured":"Massagu\u00e9 J. TGF-\u03b2 signal transduction. Annu. Rev. Biochem. 1998, 67: 753\u2013791.","journal-title":"Annu. Rev. Biochem."},{"key":"BF03344069_CR3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/321776a0","volume":"321","author":"W Vale","year":"1986","unstructured":"Vale W., Rivier J., Vaughan J. et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986, 321: 776\u2013779.","journal-title":"Nature"},{"key":"BF03344069_CR4","first-page":"211","volume-title":"Handbook of Experimental Pharmacology","author":"W Vale","year":"1990","unstructured":"Vale W., Hsueh A., Rivier C., Yu J. The inhibin\/activin family of hormones and growth factors. In: Sporn M.B., Roberts A.B. (Eds.), Handbook of Experimental Pharmacology. Springer-Verlag, Heidelberg, 1990, p. 211\u2013248."},{"key":"BF03344069_CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/edrv-9-2-267","volume":"9","author":"SY Ying","year":"1988","unstructured":"Ying S.Y. Inhibins, activins and follistatin: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr. Rev. 1988, 9: 267\u2013293.","journal-title":"Endocr. Rev."},{"key":"BF03344069_CR6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1006\/frne.1996.0013","volume":"17","author":"PG Knight","year":"1996","unstructured":"Knight P.G. Roles of inhibins, activins and follistatin in the female reproductive system. Front. Neuroendocrinol. 1996, 17: 476\u2013509.","journal-title":"Front. Neuroendocrinol."},{"key":"BF03344069_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1073\/pnas.85.1.247","volume":"85","author":"H Meunier","year":"1988","unstructured":"Meunier H., Rivier C., Evans R.M., Vale W. Gonadal and extragonadal expression of inhibin \u03b1- and \u03b2-subunits in various tissues predicts diverse functions. Proc. Natl. Acad. Sci. 1988, 85: 247\u2013251.","journal-title":"Proc. Natl. Acad. Sci."},{"key":"BF03344069_CR8","first-page":"1521","volume":"78","author":"T Tuuri","year":"1994","unstructured":"Tuuri T., Eramaa M., Hilden K., Ritvos O. The tissue distribution of activin beta-A and beta-B subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J. Clin. Endocrinol. Metab. 1994, 78: 1521\u20131524.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03344069_CR9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1172\/JCI113955","volume":"83","author":"B Grubeck-Loebenstein","year":"1989","unstructured":"Grubeck-Loebenstein B., Buchan G., Sadeghi R. et al. Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of non-toxic goiter. J. Clin. Invest. 1989, 83: 764\u2013770.","journal-title":"J. Clin. Invest."},{"key":"BF03344069_CR10","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1210\/endo.140.9.6961","volume":"140","author":"A Franzen","year":"1999","unstructured":"Franzen A., Piek E., Westermark B., ten Dijke P., Heldin N.E. Expression of transforming growth factor-beta 1, activin A and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function. Endocrinology 1999, 140: 4300\u20134310.","journal-title":"Endocrinology"},{"key":"BF03344069_CR11","doi-asserted-by":"crossref","first-page":"RC25","DOI":"10.1007\/BF03343893","volume":"24","author":"P Morpurgo","year":"2001","unstructured":"Morpurgo P., Corsi A., Corbetta S., Vicentini L., Spada A. In vitro release of activin A from human normal and pathological thyroid tissues. J. Endocrinol. Invest. 2001, 24: RC25\u2013RC27.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03344069_CR12","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/endo.136.3.7867575","volume":"136","author":"A Kotajima","year":"1995","unstructured":"Kotajima A., Miyamoto Y., Tsuruo M., Kosaka M., Saito S. Effect of activin A on deoxyribonucleic acid synthesis, iodine metabolism, and cyclic adenosine monophosphate accumulation in porcine thyroid cells. Endocrinology 1995, 136: 1214\u20131218.","journal-title":"Endocrinology"},{"key":"BF03344069_CR13","first-page":"2125","volume":"81","author":"K Harada","year":"1996","unstructured":"Harada K., Shintani Y., Sakamoto Y., Wakatsuki M., Shitsukawa K., Saito S. Serum immunoreactive activin A levels in normal subjects and patients with various diseases. J. Clin. Endocrinol. Metab. 1996, 81: 2125\u20132130.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03344069_CR14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1677\/joe.0.1480267","volume":"148","author":"PG Knight","year":"1996","unstructured":"Knight P.G., Muttukrishna S., Groome N.P. Development and application of a two-site enzyme immunoassay for the determination of \u201ctotal\u201d activin A concentrations in serum and follicular fluid. J. Endocrinol. 1996, 148: 267\u2013279.","journal-title":"J. Endocrinol."},{"key":"BF03344069_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1677\/joe.0.1610187","volume":"161","author":"B Munz","year":"1999","unstructured":"Munz B., Hubner G., Tretter Y., Alzheimer C., Werner S. A novel role of activin in inflammation and repair. J. Endocrinol. 1999, 161: 187\u2013193.","journal-title":"J. Endocrinol."},{"key":"BF03344069_CR16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/eje.0.1450505","volume":"145","author":"A Mohan","year":"2001","unstructured":"Mohan A., Asselin J., Sargent I.L., Groome N.P., Muttukrishna S. Effect of cytokines and growth factors on the secretion of inhibin A, activin A and follistatin by term placental villous trophoblasts in culture. Eur. J. Endocrinol. 2001, 145: 505\u2013511.","journal-title":"Eur. J. Endocrinol."},{"key":"BF03344069_CR17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0143-4004(98)90084-4","volume":"19","author":"JA Keelan","year":"1998","unstructured":"Keelan J.A., Groome N.P., Mitchell M.D. Regulation of activin-A production by human Amnion, decidua and placenta in vitro by proinflammatory cytokines. Placenta 1998, 19: 429\u2013434.","journal-title":"Placenta"},{"key":"BF03344069_CR18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2249.1998.00522.x","volume":"112","author":"EW Yu","year":"1998","unstructured":"Yu E.W., Dolter K.E., Shao L., Yu J. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin. Exp. Immunol. 1998, 112: 126\u2013132.","journal-title":"Clin. Exp. Immunol."},{"key":"BF03344069_CR19","first-page":"788","volume":"15","author":"AP Weetman","year":"1994","unstructured":"Weetman A.P., McGregor A.M. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 1994, 15: 788\u2013828.","journal-title":"Endocr. Rev."},{"key":"BF03344069_CR20","first-page":"19","volume-title":"Jones Institute, Norfolk","author":"AJ Mason","year":"1988","unstructured":"Mason A.J. Structure and recombinant expression of human inhibin and activin. In: Hogden G.D., Rosenwacs Z., Spieler J.M. (Eds.), Nonsteroidal gonadal factors: physiological roles and possibilities in contraceptive development. Jones Institute, Norfolk, 1988, p. 19\u201335."},{"key":"BF03344069_CR21","first-page":"534","volume":"10","author":"KA Coerver","year":"1996","unstructured":"Coerver K.A., Woodruff T.K., Finegold M.J., Mather J., Bradley A., Matzuk M.M. Activin signalling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Mol. Endocrinol. 1996, 10: 534\u2013543.","journal-title":"Mol. Endocrinol."},{"key":"BF03344069_CR22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0006-291X(92)91799-V","volume":"182","author":"K Tanimoto","year":"1992","unstructured":"Tanimoto K., Tamura K., Ueno N., Usuki S., Murakami K., Fukamizu A. Regulation of activin \u03b2A mRNA level by cAMP. Biochem. Biophys. Res. Commun. 1992, 182: 773\u2013778.","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03344069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03344069\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03344069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T13:07:44Z","timestamp":1565356064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03344069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["BF03344069"],"URL":"https:\/\/doi.org\/10.1007\/bf03344069","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}